News
More and more companies are investing in developing GLP-1R agonists, including dual and triple agonists and combination ...
7h
Civic Science on MSNGLP-1 Trends by CivicScience: Costs Emerge as a Barrier Amid Uncertainty, But Emotional Wellbeing ImprovesThis is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on more ...
Weightloss drugs can also cause what is known as Ozempic hands. As with the feet and face, these areas show fat loss more ...
Bariatric surgery and GLP-1s conferred similar outcomes in mortality, adverse cardiovascular events and cirrhosis development ...
20h
Lose It! on MSNShould I Take a Supplement If I Am on a GLP-1?If you experience symptoms like muscle cramping, irregular or fast heart rate, headaches, fatigue, nausea and vomiting, ...
As weight loss medications, including Ozempic and WeGovy, have gained popularity across the U.S., they are not without side effects, some serious. According to a May 2024 CNN report, as many as 1 in 8 ...
Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a pill.
13h
Lose It! on MSNWhat’s Your GLP-1 Drug IQ? Take Our QuizDepending on the drug and dosage, you may lose upwards of 21 percent of your body weight after taking a GLP-1 for a year.
WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with weight-loss drugs like Ozempic. The company ...
From Meghan Trainor to Oprah Winfrey, here are 10 celebrities who took weight-loss drugs to slim down and achieve a healthier lifestyle.
Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results